Näytä suppeat kuvailutiedot

dc.contributor.authorKarjula, Topias
dc.contributor.authorElomaa, Hanna
dc.contributor.authorNiskakangas, Anne
dc.contributor.authorMustonen, Olli
dc.contributor.authorPuro, Iiris
dc.contributor.authorKuopio, Teijo
dc.contributor.authorAhtiainen, Maarit
dc.contributor.authorMecklin, Jukka-Pekka
dc.contributor.authorSeppälä, Toni, T.
dc.contributor.authorWirta, Erkki-Ville
dc.contributor.authorSihvo, Eero
dc.contributor.authorVäyrynen, Juha, P.
dc.contributor.authorYannopoulos, Fredrik
dc.contributor.authorHelminen, Olli
dc.date.accessioned2023-01-31T12:17:39Z
dc.date.available2023-01-31T12:17:39Z
dc.date.issued2023
dc.identifier.citationKarjula, T., Elomaa, H., Niskakangas, A., Mustonen, O., Puro, I., Kuopio, T., Ahtiainen, M., Mecklin, J.-P., Seppälä, T., Wirta, E.-V., Sihvo, E., Väyrynen, J., Yannopoulos, F., & Helminen, O. (2023). CD3+ and CD8+ T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer. <i>Cancers</i>, <i>15</i>(1), Article 206. <a href="https://doi.org/10.3390/cancers15010206" target="_blank">https://doi.org/10.3390/cancers15010206</a>
dc.identifier.otherCONVID_176467955
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/85263
dc.description.abstractSimple Summary The lung is the second most common site of metastases in colorectal cancer (CRC). The aim of our study was to evaluate the prognostic value of CD3+ and CD8+ T-cell density based immune cell score (ICS) and PD-1/PD-L1 expression in resected pulmonary metastases of microsatellite stable CRC. The T-cell infiltration was higher in the first pulmonary metastases compared to primary tumour. Pulmonary metastases with high ICS had improved survival compared to low ICS after adjusting for confounders. High tumour cell PD-L1 expression was associated with favourable prognosis. Our results might have clinical feasibility in planning future therapies. Abstract The objective of this study was to evaluate the prognostic value of CD3+ and CD8+ based immune cell score (ICS), programmed death -1 (PD-1) and programmed death ligand -1 (PD-L1) in pulmonary metastases of proficient mismatch repair colorectal cancer (CRC) patients. A total of 101 pulmonary metastases and 62 primary CRC tumours were stained for CD3+, CD8+, PD-1 and PD-L1 expression. The prognostic value of ICS, PD-1/PD-L1 expression in 67 first pulmonary metastases and 61 primary CRC tumour was analysed. Comparative analysis was also performed between primary tumours and pulmonary metastases, as well as between T-cell densities and PD-1/PD-L1 expression. The 5-year overall survival rates of low, intermediate, and high ICS in pulmonary metastases were 10.0%, 25.5% and 47.0% (p = 0.046), respectively. Patients with high vs. low ICS in pulmonary metastases had a significantly better 5-year survival (adjusted HR 0.25, 95% CI 0.09–0.75, p = 0.013). High tumour cell PD-L1 expression in the pulmonary metastases was associated with improved survival (p = 0.024). Primary tumour CD8+ expression was significantly correlated with all T-cell densities in pulmonary metastases. Conclusion: The ICS evaluated from the resected pulmonary metastases of CRC showed significant prognostic value. High PD-L1 expression in pulmonary metastases is associated with favourable prognosis.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.ispartofseriesCancers
dc.rightsCC BY 4.0
dc.subject.othercolorectal carcinoma
dc.subject.otherpulmonary metastases
dc.subject.othertumour-infiltrating lymphocytes
dc.subject.otherprogrammed death 1
dc.subject.otherprogrammed death ligand 1
dc.titleCD3+ and CD8+ T-Cell-Based Immune Cell Score and PD-(L)1 Expression in Pulmonary Metastases of Microsatellite Stable Colorectal Cancer
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-202301311548
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosBio- ja ympäristötieteiden laitosfi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.contributor.laitosDepartment of Biological and Environmental Scienceen
dc.contributor.oppiaineSolu- ja molekyylibiologiafi
dc.contributor.oppiaineGerontologia ja kansanterveysfi
dc.contributor.oppiaineCell and Molecular Biologyen
dc.contributor.oppiaineGerontology and Public Healthen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn2072-6694
dc.relation.numberinseries1
dc.relation.volume15
dc.type.versionpublishedVersion
dc.rights.copyright© 2022 by the authors. Licensee MDPI, Basel, Switzerland
dc.rights.accesslevelopenAccessfi
dc.subject.ysoetäpesäkkeet
dc.subject.ysokarsinoomat
dc.subject.ysokeuhkot
dc.subject.ysopaksusuolisyöpä
dc.subject.ysosyöpätaudit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p2298
jyx.subject.urihttp://www.yso.fi/onto/yso/p28373
jyx.subject.urihttp://www.yso.fi/onto/yso/p3185
jyx.subject.urihttp://www.yso.fi/onto/yso/p5937
jyx.subject.urihttp://www.yso.fi/onto/yso/p678
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.3390/cancers15010206
jyx.fundinginformationThis study was funded by Instrumentarium Science Foundation (O.H.), Mary and Georg C. Ehrnrooth Foundation (O.H.), Finnish State Research Funding (O.H.), and Cancer Foundation Finland (J.P.V.), J&A Erkko Foundation (J.-P.M.).
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY 4.0